Johnson & Johnson shares traded lower despite beating earnings. It turns out that there are some issues outside of earnings that shareholders are having a hard time quantifying.
Jon C. Ogg Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.
Chris Lange Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of Johnson & Johnson, Microsoft, Netflix and the other most prominent of the many earnings reports that are expected this week.
24/7 Wall St. screened the top ESG ETFs to see how they differ or are similar. It turns out that these funds have severe overlaps, with Microsoft, Apple, Johnson & Johnson, Alphabet,…
After a review of the analyst calls for the week of May 17, 10 stocks stood out. They have either large market caps or are well known to the public, and Wall…
The top analyst upgrades, downgrades and initiations seen on Thursday included Cisco Systems, Deere, Dillard's, Johnson & Johnson, L3 Technologies, Macy's, Occidental Petroleum, SunRun and Valero Energy.
Here is a slate of 15 companies that most retirees likely would want to own in their portfolio now, including AT&T, Boeing, Pfizer and Walmart.
Johnson & Johnson released better-than-expected first-quarter financial results before the markets opened on Tuesday.
Chris Lange Johnson & Johnson is scheduled to release its first-quarter financial results before the markets open on Tuesday, and expectations are muted.
Chris Lange During times of uncertainty and fear, many investors have to look for a place to hide when they know that they have to keep having income from investments to supplement their income,…
Johnson & Johnson shares dipped on Thursday on news that a California jury awarded $29 million to a woman that claimed its talcum-powder-based products caused her cancer.
Chris Lange It's no secret that investors love dividends. Here are 10 solid companies that have raised dividends for their investors for at least 50 consecutive years.
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Johnson & Johnson still cannot escape the shadow of its Johnson's Baby Powder brand talc and asbestos lawsuits and overhang.
Jon C. Ogg 
